TCF7L2 and prostate cancer: In conclusion, the results indicated that there was a significantly association between TCF7L2 rs7903146 polymorphism and the risk of breast cancer, prostate cancer and colon cancer, rather than colorectal cancer, lung cancer, and ovarian cancer.